Richard Kim

20PUBLICATIONS
52CO-AUTHORS
Predictive and prognostic markersCancer diagnosisEpidemiological methodsMolecular targetsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Oct 15, 2026
Real-world outcomes in circulating tumor DNA-detected isocitrate dehydrogenase 1-mutant cholangiocarcinoma: First-line gemcitabine and cisplatin with versus without immunotherapy.

|Jun 29, 2026
Implementing Timely Germline Genetic Testing for Patients With Pancreatic Cancer Using a Genetics Copilot for Point-of-Care Education and Health Assessment.

|Sep 27, 2025
Linkage disequilibrium score regression identifies genetic correlations between hepatocellular carcinoma and clinically relevant traits.

Younghun Han, Vikram R Shaw, Jinyoung Byun

|Jan 08, 2025
Detecting Early Recurrence With Circulating Tumor DNA in Stage I-III Biliary Tract Cancer After Curative Resection.

James Yu, Aiwu Ruth He, Mahmoud Ouf

|Aug 22, 2024
Real-world use of pemigatinib for the treatment of cholangiocarcinoma in the US.

Kim Saverno, Kristin M Zimmerman Savill, Cherrishe Brown-Bickerstaff

|Jun 17, 2024
Real-World Effectiveness of First Line Lenvatinib Therapy in Advanced Hepatocellular Carcinoma: Current Insights.

Tiago Biachi de Castria, Richard D Kim

Pageof 4

Frequent Collaborators

2 joint publications

Elaine Tan

2 joint publications

Jennifer B Permuth

2 joint publications

Ibrahim Halil Sahin

1 joint publications

Hanna K Sanoff